422 related articles for article (PubMed ID: 9653172)
1. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.
Delecluse HJ; Hilsendegen T; Pich D; Zeidler R; Hammerschmidt W
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8245-50. PubMed ID: 9653172
[TBL] [Abstract][Full Text] [Related]
2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus and the B cell: that's all it takes.
Thorley-Lawson DA; Miyashita EM; Khan G
Trends Microbiol; 1996 May; 4(5):204-8. PubMed ID: 8727601
[TBL] [Abstract][Full Text] [Related]
4. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
[TBL] [Abstract][Full Text] [Related]
5. The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.
Delecluse HJ; Hammerschmidt W
Mol Pathol; 2000 Oct; 53(5):270-9. PubMed ID: 11091851
[TBL] [Abstract][Full Text] [Related]
6. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.
Takasaka N; Tajima M; Okinaga K; Satoh Y; Hoshikawa Y; Katsumoto T; Kurata T; Sairenji T
Virology; 1998 Aug; 247(2):152-9. PubMed ID: 9705908
[TBL] [Abstract][Full Text] [Related]
7. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.
Kanda T; Furuse Y; Oshitani H; Kiyono T
J Virol; 2016 May; 90(9):4383-93. PubMed ID: 26889033
[TBL] [Abstract][Full Text] [Related]
8. Non-correlation of in vivo and in vitro parameters of Epstein-Barr virus persistence suggests heterogeneity of B cell infection.
Johannessen I; Haque T; N'Jie-Jobe J; Crawford DH
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1631-6. PubMed ID: 9680124
[TBL] [Abstract][Full Text] [Related]
9. Infection and persistence of rhesus monkey rhadinovirus in immortalized B-cell lines.
Bilello JP; Lang SM; Wang F; Aster JC; Desrosiers RC
J Virol; 2006 Apr; 80(7):3644-9. PubMed ID: 16537632
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
11. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
12. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
13. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.
McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS
Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507
[TBL] [Abstract][Full Text] [Related]
14. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
15. Immortalization of human primary B lymphocytes in vitro with DNA.
Kempkes B; Pich D; Zeidler R; Hammerschmidt W
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5875-9. PubMed ID: 7597045
[TBL] [Abstract][Full Text] [Related]
16. EBV infection of T cells: potential role in malignant transformation.
Kelleher CA; Dreyfus DH; Jones JF; Gelfand EW
Semin Cancer Biol; 1996 Aug; 7(4):197-207. PubMed ID: 8946604
[TBL] [Abstract][Full Text] [Related]
17. [Features of adult T-cell leukemia virus reproduction in B-cell lines and it's interaction with the Epstein-Barr herpesvirus].
Iakovleva LS; Pavlish OA; Syrtsev AV; Galetskiĭ SA; Dushen'kina TE; Gurtsevich VE
Vopr Virusol; 1997; 42(2):77-81. PubMed ID: 9182405
[TBL] [Abstract][Full Text] [Related]
18. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
[TBL] [Abstract][Full Text] [Related]
19. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
20. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells.
Shimizu N; Yoshiyama H; Takada K
J Virol; 1996 Oct; 70(10):7260-3. PubMed ID: 8794379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
